NeuroQ 3.0

PET scan analysis tool

Finn lignende produkter

NeuroQ 3.0™ is a powerful tool to assist clinicians with interpretations of brain PET scans. NeuroQ helps with the differential diagnosis of dementia and allows a physician to monitor the progress of a patient’s disease.

Features
Automated analysis

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.
Anomaly detection

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.
Built-in comparison

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.
Optional EQuAL

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.
  • Automated analysis
  • Anomaly detection
  • Built-in comparison
  • Optional EQuAL
See all features
Automated analysis

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.

Automated analysis for disease monitoring

NeuroQ 3.0 helps you save time with its automated analysis and quantification of relative activity in multiple brain regions. It's a user-friendly clinical tool that can automatically identify and quantify differences between two FDG-PET studies of the same patient.
Anomaly detection

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.

Anomaly detection helps diagnostics

NeuroQ 3.0 helps detect clinically meaningful abnormalities of regional brain metabolism.
Built-in comparison

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.

Built-in comparison with asymptomatic control subjects

NeuroQ 3.0 compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects.
Optional EQuAL

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

Optional EQuAL helps determine prognosis of TLE surgery

NeuroQ 3.0 offers an optional application called EQuAL, which is a unique neuro imaging analysis tool for brain PET imaging of temporal lobe epilepsy (TLE). EQuAL analysis provides a non-invasive way to determine, in advance of TLE surgery, the likelihood that a patient will become seizure-free after surgery.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Nettstedet vises best med den nyeste versjonen av Microsoft Edge, Google Chrome eller Firefox.